Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

2010/05/06 by Batya B. Davidovici, Naveed Sattar, Prinz C. Jörg +10 · 705 citations
Immunology and Microbiology · Medicine · #Asthma and respiratory diseases #Dermatology #Dermatology and Skin Diseases #Disease #Immunology #Inflammation #Medicine #Pathology #Psoriasis #Psoriasis: Treatment and Pathogenesis #Systemic inflammation

paper · pdf · doi:10.1038/jid.2010.103

published in Journal of Investigative Dermatology 130(7), 1785-1796 (Elsevier BV)

openalex publication_date 2010/05/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Citations

• Leptin in Immunology
• C-reactive protein: a critical update
• Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
• Obesity is associated with macrophage accumulation in adipose tissue

Cited by

• Deep phenotyping for precision medicine
• Cutaneous adipose tissue carries a strong inflammatory signature in patients with psoriasis
• Immunology of Psoriasis
• The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis
• Resolved psoriasis lesions retain expression of a subset of disease-related genes. [europepmc]
• Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. [europepmc]
• Attributable risk estimate of severe psoriasis on major cardiovascular events. [europepmc]
• Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. [europepmc]
• Obesity and risk of incident psoriatic arthritis in US women. [europepmc]
• Putting together the psoriasis puzzle: an update on developing targeted therapies. [europepmc]
• Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. [europepmc]
• The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. [europepmc]
• Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. [europepmc]
• Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. [europepmc]
• Immunology of psoriasis. [europepmc]
• Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). [europepmc]
• The immunogenetics of Psoriasis: A comprehensive review. [europepmc]
• The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases. [europepmc]
• Psoriasis and comorbid diseases: Epidemiology. [europepmc]
• The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. [europepmc]
• Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. [europepmc]
• Psoriasis and the risk of diabetes: A prospective population-based cohort study. [europepmc]
• Scanning the Immunopathogenesis of Psoriasis. [europepmc]
• Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. [europepmc]
• Management of psoriasis as a systemic disease: what is the evidence? [europepmc]
• Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. [europepmc]
• Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities. [europepmc]
• Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields. [europepmc]
• Role of Insulin in Health and Disease: An Update. [europepmc]